Bath & Body Works
BBWI
$20.49
+2.96%
Bath & Body Works, Inc. is a specialty retailer of home fragrance and fragrant body care products, operating primarily through its Bath & Body Works, C.O. Bigelow, and White Barn brands. As a dominant player in the U.S. specialty retail sector, the company leverages a vast brick-and-mortar network of over 1,900 stores, which generated 77% of fiscal 2025 sales, alongside a growing digital and international presence. The current investor narrative centers on the company's ability to navigate a challenging consumer environment, with same-store sales declining and a focus on cost optimization, store upgrades, and category expansion into men's and lip products to reignite growth. Recent attention has been drawn to the stock's significant price decline and the debate over whether its low valuation reflects a value opportunity or structural headwinds.…
BBWI
Bath & Body Works
$20.49
Investment Opinion: Should I buy BBWI Today?
Rating: Hold. BBWI is a high-risk, deep-value play with a compelling free cash flow yield but significant financial and operational headwinds. The consensus analyst rating is 'hold' with an average target of $25.13, implying 26% upside, but the wide dispersion and recent downgrades suggest caution. The thesis is that the stock is cheap for a reason, and while a turnaround is possible, the risks are elevated.
Supporting Evidence: The trailing P/E of 7.1x is well below the industry average of 15x, but this discount is justified by negative revenue growth (-3.23% YoY) and negative equity. The company is profitable with a net margin of 13.28% and generates strong FCF ($909 million TTM), which supports a 3.6% dividend yield. However, the negative ROE of -50.7% signals that the company is not generating adequate returns on equity. The forward P/E of 6.95x implies minimal earnings growth expectations, consistent with the revenue decline.
Risks & Conditions: The biggest risks are further revenue contraction and inability to de-lever. If same-store sales continue to decline, the stock could test the 52-week low of $14.28. This Hold would upgrade to Buy if revenue growth turns positive and the company demonstrates a credible path to reducing debt, or if the P/E compresses below 5x. It would downgrade to Sell if free cash flow deteriorates or if the company announces a dividend cut. Overall, BBWI appears undervalued on a P/E basis relative to history and peers, but the valuation is justified by the high financial risk and declining top line.
Sign up to view all
BBWI 12-Month Price Forecast
BBWI faces significant headwinds from declining revenue and a leveraged balance sheet, which the low valuation (7.1x P/E) only partially compensates for. The stock's negative momentum and underperformance relative to the market suggest that the risk of further downside is elevated. While the company generates strong free cash flow, the negative equity and high debt levels create financial fragility. The base case of continued revenue decline and range-bound trading appears most likely. A bullish stance would require evidence of a sales turnaround, which is not yet visible. The stance would upgrade to neutral if revenue stabilizes or if the company announces a significant debt reduction plan.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bath & Body Works's 12-month outlook, with a consensus price target around $25.13 and implied upside of +22.7% versus the current price.
Average Target
$25.13
0 analysts
Implied Upside
+22.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $54
Analyst target range
BBWI is covered by 15 analysts, with a consensus recommendation of 'hold' (mean rating 2.67 on a 1-5 scale, where 1 is strong buy). The average target price is $25.13, implying approximately +26.3% upside from the current price of $19.90. The distribution leans neutral, with recent actions including a downgrade to 'Sell' by Goldman Sachs (July 2026) and a maintained 'Overweight' by Wells Fargo, indicating mixed sentiment. The target range spans from a low of $19.00 to a high of $54.00. The wide spread (low to high difference of $35) signals high uncertainty about the company's future. The high target of $54.00 assumes a significant turnaround, possibly driven by successful category expansion or margin recovery, while the low target of $19.00 suggests continued revenue decline and potential financial distress. Recent downgrades from Goldman Sachs and neutral stances from Barclays and UBS highlight caution, while TD Cowen's 'Buy' rating provides a bullish counterpoint. The overall consensus reflects a wait-and-see approach as the company navigates its challenges.
Drowning in data?
Find the real signal!
Bulls vs Bears: BBWI Investment Factors
BBWI presents a classic value trap debate: on one hand, the stock trades at a deep discount (7.1x P/E) with strong free cash flow and improving margins, suggesting a potential turnaround. On the other hand, revenue is declining, the balance sheet is strained (negative equity), and the stock is in a sustained downtrend. The bull case hinges on the company stabilizing sales and using its cash flow to de-lever, while the bear case argues that structural headwinds in specialty retail will continue to erode earnings. The single most important tension is whether the low valuation adequately compensates for the risk of further revenue deterioration and financial distress. Currently, the bearish evidence is stronger given the negative momentum and leverage, but the deep value discount provides a compelling contrarian argument.
Bullish
- Deep Value at 7.1x Trailing P/E: BBWI trades at a trailing P/E of 7.1x, a 53% discount to the specialty retail industry average of ~15x. This low multiple suggests the market has priced in significant pessimism, offering a potential margin of safety if the company stabilizes.
- Strong Free Cash Flow Generation: The company generated $909 million in free cash flow over the trailing twelve months, providing ample liquidity to service debt, fund dividends (3.6% yield), and invest in store upgrades. This cash flow supports the balance sheet despite negative equity.
- Improving Operating Margins: Operating margin improved to 16.76% in Q1 2026 from 14.68% a year ago, reflecting successful cost control measures. This demonstrates management's ability to protect profitability even as revenue declines.
- Analyst Target Implies 26% Upside: The average analyst price target of $25.13 implies approximately 26.3% upside from the current price of $19.90. While the consensus is 'hold', the target suggests analysts see modest recovery potential.
Bearish
- Declining Revenue Trend: Revenue fell 3.23% YoY in Q1 2026 to $1.378 billion, continuing a multi-quarter pattern of contraction. The core brick-and-mortar segment, which generates 77% of sales, faces structural headwinds from shifting consumer behavior.
- Negative Equity and High Leverage: The debt-to-equity ratio of -3.87 reflects negative shareholders' equity, a red flag for financial health. With a debt ratio of 0.95, the company is highly leveraged, increasing vulnerability to earnings shocks.
- Negative ROE of -50.7%: Return on equity is deeply negative at -50.7%, indicating the company is destroying shareholder value. This metric underscores the risk of investing in a firm with a leveraged capital structure and declining earnings.
- Sustained Downtrend and Underperformance: BBWI's 1-year price change of -36.68% dramatically underperforms the S&P 500's +16.47%. The stock trades near the low end of its 52-week range ($14.28-$32.32), reflecting persistent selling pressure and negative momentum.
BBWI Technical Analysis
BBWI is in a sustained downtrend, with a 1-year price change of -36.68%, significantly underperforming the S&P 500's +16.47% gain. The current price of $19.90 sits at 61.6% of its 52-week range (low $14.28, high $32.32), indicating it is closer to the low end. This positioning suggests the stock is deeply out of favor, potentially offering a value opportunity if fundamentals stabilize, but also risks further downside if negative momentum persists. The 52-week low of $14.28 provides a critical support level, while the high of $32.32 represents a distant resistance. With a beta of 1.353, BBWI is about 35% more volatile than the market, amplifying both upside and downside risks.
Beta
1.35
1.35x market volatility
Max Drawdown
-55.9%
Largest decline past year
52-Week Range
$14-$32
Price range past year
Annual Return
-35.1%
Cumulative gain past year
| Period | BBWI Return | S&P 500 |
|---|---|---|
| 1m | -10.4% | +1.4% |
| 3m | +6.4% | +3.9% |
| 6m | -5.3% | +6.3% |
| 1y | -35.1% | +16.0% |
| ytd | -1.2% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BBWI Fundamental Analysis
Revenue has been declining, with the most recent quarter (Q1 2026) reporting $1.378 billion, a -3.23% year-over-year drop. This marks a continuation of a multi-quarter trend of decelerating growth, as Q4 2025 revenue was $2.724 billion (down from $2.787 billion a year earlier) and Q3 2025 revenue was $1.594 billion (down from $1.610 billion). The company's core brick-and-mortar segment is under pressure, while digital and international channels offer modest offsets. The declining top line raises concerns about market share loss and consumer spending shifts, making the investment case dependent on a reversal of this trend. Despite revenue headwinds, BBWI remains profitable, with net income of $183 million in Q1 2026 and a net margin of 13.28%. Gross margin has been relatively stable, at 42.6% in Q1 2026, though down from 45.4% in Q1 2025, indicating some cost pressure. Operating margin improved to 16.76% in Q1 2026 from 14.68% a year ago, reflecting cost control measures. However, the negative ROE of -50.74% signals that the company's equity is negative due to high debt, which is a red flag for financial health. BBWI generated $909 million in free cash flow over the trailing twelve months, a strong figure that supports dividends and debt servicing. The current ratio of 1.27 suggests adequate liquidity, but the debt-to-equity ratio of -3.87 (negative equity) indicates significant leverage. The company's ability to generate cash is a positive, but the high debt load (debt ratio of 0.95) poses financial risk, especially if earnings deteriorate further.
Quarterly Revenue
$1.4B
2026-05
Revenue YoY Growth
-3.2%
YoY Comparison
Gross Margin
42.6%
Latest Quarter
Free Cash Flow
$909000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BBWI Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 7.10x, while the forward P/E is 6.95x, implying the market expects slightly higher earnings in the coming year. The narrow gap suggests limited growth expectations, consistent with the company's revenue decline. Compared to the specialty retail industry average P/E of approximately 15x, BBWI trades at a 53% discount, reflecting its shrinking revenue and negative equity. This discount may be justified by the company's weak growth trajectory and high leverage, but it also suggests the market is pricing in significant pessimism. Historically, BBWI's trailing P/E has ranged from 2.87x (Q4 2025) to 52.34x (Q3 2021). The current 7.10x is near the low end of its historical range, indicating that the stock is cheap relative to its own past. This could imply a value opportunity if the company stabilizes, but it also reflects the market's skepticism about future earnings power.
PE
7.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: BBWI's primary financial risk is its high leverage, with a debt-to-equity ratio of -3.87 and a debt ratio of 0.95, meaning debt nearly equals total assets. Negative equity of over $1 billion implies that liabilities exceed assets, leaving little cushion for creditors. While the company generated $909 million in FCF, interest expense of $69 million per quarter (annualized ~$276 million) consumes a significant portion of operating income. Revenue concentration in brick-and-mortar (77% of sales) exposes the company to mall traffic declines and changing consumer preferences. The declining top line (-3.23% YoY) could pressure margins further if fixed costs cannot be reduced proportionally.
Market & Competitive Risks: The stock's beta of 1.353 indicates 35% higher volatility than the market, amplifying downside during selloffs. Trading at a 53% discount to the industry average P/E, the stock is already pricing in significant pessimism, but further de-rating is possible if earnings disappoint. Competitive risks include encroachment from online retailers and shifting consumer spending toward experiences versus goods. The recent downgrade by Goldman Sachs to 'Sell' (July 2026) highlights analyst skepticism, while the wide target range ($19-$54) reflects high uncertainty. Macroeconomic headwinds, such as persistent inflation or a recession, could further pressure discretionary spending on home fragrance and body care.
Worst-Case Scenario: In a severe downturn, continued revenue declines could lead to covenant breaches on debt, forcing asset sales or equity dilution. If the company cannot generate sufficient FCF to service debt, a restructuring or bankruptcy becomes a tail risk. The 52-week low of $14.28 represents a potential 28% downside from the current price of $19.90. In a worst-case scenario mirroring the historical max drawdown of -55.87%, the stock could fall to approximately $8.78, implying a loss of 56% from current levels. This scenario would likely require a sustained recession and a sharp drop in consumer spending.
FAQ
The primary risk is financial: BBWI has negative equity of over $1 billion and a debt-to-equity ratio of -3.87, meaning liabilities exceed assets. This high leverage makes the company vulnerable to earnings shocks. Second, revenue is declining (-3.23% YoY), and if this trend accelerates, it could pressure margins and free cash flow. Third, the stock has high volatility (beta 1.353) and is in a downtrend, with a 1-year return of -36.68% versus the S&P 500's +16.47%. Fourth, the company faces competitive risks from online retailers and changing consumer preferences. The most severe risk is a potential dividend cut or debt restructuring if cash flow deteriorates.
The 12-month outlook is uncertain, with three scenarios. The base case (50% probability) sees continued revenue decline of 2-4%, with the stock trading in a $19-$25 range, near the average analyst target of $25.13. The bull case (20% probability) assumes a sales stabilization and margin improvement, pushing the stock to $25-$32. The bear case (30% probability) involves accelerating revenue declines and potential dividend cuts, with the stock falling to $14-$19, possibly retesting the 52-week low of $14.28. The most likely outcome is the base case, given the lack of catalysts for a turnaround. The AI assessment is bearish with medium confidence, citing declining revenue and negative equity as key concerns.
BBWI appears undervalued on a P/E basis, trading at 7.1x trailing earnings versus the specialty retail industry average of 15x, a 53% discount. Historically, the stock's P/E has ranged from 2.87x to 52.34x, so the current level is near the low end. However, the low multiple is justified by declining revenue, negative equity, and high leverage. The market is pricing in significant pessimism, which could be either a value opportunity or a value trap. On a price-to-sales basis, the PS ratio of 0.63 is also low, but this reflects the lack of growth. Overall, the stock is cheap relative to history and peers, but the valuation is fair given the fundamental challenges.
BBWI is a high-risk, high-reward proposition. On the positive side, the stock trades at a trailing P/E of 7.1x, a 53% discount to the specialty retail average, and offers a 3.6% dividend yield backed by strong free cash flow of $909 million. However, revenue is declining (-3.23% YoY), the company has negative equity, and the stock is in a sustained downtrend. The average analyst target of $25.13 implies 26% upside, but the consensus is 'hold' with a recent downgrade from Goldman Sachs. For risk-tolerant investors with a long-term horizon, it could be a contrarian buy if they believe the company can stabilize sales. For most investors, the risks outweigh the potential reward, making it a 'hold' at best.
BBWI is better suited for long-term, contrarian investors who can tolerate high volatility and are willing to wait for a potential turnaround. The stock's beta of 1.353 and sustained downtrend make it risky for short-term trading, as negative momentum could persist. The company's high leverage and declining revenue suggest that any recovery will take time, likely 2-3 years if it materializes. The dividend yield of 3.6% provides some income, but it is not guaranteed. Short-term traders may find opportunities around earnings reports, but the overall trend is bearish. A minimum holding period of 2-3 years is recommended for those betting on a recovery.
